Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Public ClinicalTrials.gov record NCT02513160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 6-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) at 320 or 640 mcg/Day in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of beclomethasone dipropionate administered via BAI at a dose strength of 40 or 80 mcg per oral inhalation (320 or 640 mcg/day, respectively) compared with placebo treatment in patients with persistent asthma as assessed by the standardized baseline-adjusted trough morning (pre-dose and pre-rescue bronchodilator) forced expiratory volume in 1 second (FEV1) area under the effect curve from time 0 to 6 weeks (AUEC\[0-6wk\]).
Study identification
- NCT ID
- NCT02513160
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 713 participants
Conditions and interventions
Conditions
Interventions
- Beclomethasone Dipropionate 640 Drug
- Placebo Drug
- Beclomethasone dipropionate via 320 mcg BAI Drug
- albuterol/salbutamol Drug
- Beclomethasone dipropionate via 320 mcg MDI Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2015 (Actual)
- Primary completion
- Mar 31, 2016 (Actual)
- Completion
- Mar 31, 2016 (Actual)
- Last update posted
- Nov 9, 2021
2015 – 2016
United States locations
- U.S. sites
- 75
- U.S. states
- 25
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 13415 | Peoria | Arizona | — | — |
| Teva Investigational Site 13389 | Downey | California | — | — |
| Teva Investigational Site 13421 | Huntington Beach | California | — | — |
| Teva Investigational Site 13434 | Huntington Beach | California | — | — |
| Teva Investigational Site 13427 | Los Angeles | California | — | — |
| Teva Investigational Site 13386 | Mission Viejo | California | — | — |
| Teva Investigational Site 13394 | Orange | California | — | — |
| Teva Investigational Site 13417 | Riverside | California | — | — |
| Teva Investigational Site 13445 | Rolling Hills Estates | California | — | — |
| Teva Investigational Site 13420 | San Diego | California | — | — |
| Teva Investigational Site 13443 | San Diego | California | — | — |
| Teva Investigational Site 13438 | San Jose | California | — | — |
| Teva Investigational Site 13397 | Centennial | Colorado | — | — |
| Teva Investigational Site 13454 | Denver | Colorado | — | — |
| Teva Investigational Site 13404 | Aventura | Florida | — | — |
| Teva Investigational Site 13458 | Hialeah | Florida | — | — |
| Teva Investigational Site 13416 | Miami | Florida | — | — |
| Teva Investigational Site 13440 | Miami | Florida | — | — |
| Teva Investigational Site 13455 | Miami | Florida | — | — |
| Teva Investigational Site 13431 | Ormond Beach | Florida | — | — |
| Teva Investigational Site 13437 | Sarasota | Florida | — | — |
| Teva Investigational Site 13425 | Tallahassee | Florida | — | — |
| Teva Investigational Site 13450 | Normal | Illinois | — | — |
| Teva Investigational Site 13448 | River Forest | Illinois | — | — |
| Teva Investigational Site 13408 | Lenexa | Kansas | — | — |
| Teva Investigational Site 13410 | Baltimore | Maryland | — | — |
| Teva Investigational Site 13422 | Bethesda | Maryland | — | — |
| Teva Investigational Site 13435 | Wheaton | Maryland | — | — |
| Teva Investigational Site 13411 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 13398 | Plymouth | Minnesota | — | — |
| Teva Investigational Site 13429 | Plymouth | Minnesota | — | — |
| Teva Investigational Site 13433 | Columbia | Missouri | — | — |
| Teva Investigational Site 13432 | Rolla | Missouri | — | — |
| Teva Investigational Site 13414 | St Louis | Missouri | — | — |
| Teva Investigational Site 13430 | St Louis | Missouri | — | — |
| Teva Investigational Site 13384 | Bellevue | Nebraska | — | — |
| Teva Investigational Site 13392 | Brick | New Jersey | — | — |
| Teva Investigational Site 13426 | Ocean City | New Jersey | — | — |
| Teva Investigational Site 13419 | Skillman | New Jersey | — | — |
| Teva Investigational Site 13388 | Rochester | New York | — | — |
| Teva Investigational Site 13441 | Hickory | North Carolina | — | — |
| Teva Investigational Site 13403 | Raleigh | North Carolina | — | — |
| Teva Investigational Site 13405 | Wilmington | North Carolina | — | — |
| Teva Investigational Site 13395 | Canton | Ohio | — | — |
| Teva Investigational Site 13396 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 13436 | Sylvania | Ohio | — | — |
| Teva Investigational Site 13423 | Toledo | Ohio | — | — |
| Teva Investigational Site 13387 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 13453 | Eugene | Oregon | — | — |
| Teva Investigational Site 13439 | Lake Oswego | Oregon | — | — |
| Teva Investigational Site 13402 | Medford | Oregon | — | — |
| Teva Investigational Site 13412 | Portland | Oregon | — | — |
| Teva Investigational Site 13391 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 13449 | East Providence | Rhode Island | — | — |
| Teva Investigational Site 13456 | Warwick | Rhode Island | — | — |
| Teva Investigational Site 13413 | North Charleston | South Carolina | — | — |
| Teva Investigational Site 13390 | Knoxville | Tennessee | — | — |
| Teva Investigational Site 13442 | Knoxville | Tennessee | — | — |
| Teva Investigational Site 13400 | Austin | Texas | — | — |
| Teva Investigational Site 13452 | Boerne | Texas | — | — |
| Teva Investigational Site 13407 | Dallas | Texas | — | — |
| Teva Investigational Site 13424 | Dallas | Texas | — | — |
| Teva Investigational Site 13409 | El Paso | Texas | — | — |
| Teva Investigational Site 13451 | Houston | Texas | — | — |
| Teva Investigational Site 13399 | New Braunfels | Texas | — | — |
| Teva Investigational Site 13393 | San Antonio | Texas | — | — |
| Teva Investigational Site 13444 | San Antonio | Texas | — | — |
| Teva Investigational Site 13446 | San Antonio | Texas | — | — |
| Teva Investigational Site 13457 | San Antonio | Texas | — | — |
| Teva Investigational Site 13459 | San Antonio | Texas | — | — |
| Teva Investigational Site 13383 | Waco | Texas | — | — |
| Teva Investigational Site 13401 | South Burlington | Vermont | — | — |
| Teva Investigational Site 13385 | Richmond | Virginia | — | — |
| Teva Investigational Site 13447 | Richmond | Virginia | — | — |
| Teva Investigational Site 13428 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02513160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02513160 live on ClinicalTrials.gov.